opaque flat caps (RainDance Technologies)
90
Structured Review
RainDance Technologies
opaque flat caps
Opaque Flat Caps, supplied by RainDance Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/opaque+flat+caps/opaque+flat+caps/pmc06180520-56-5-8
Average 90 stars, based on 1 article reviews
Opaque Flat Caps, supplied by RainDance Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/opaque+flat+caps/opaque+flat+caps/pmc06180520-56-5-8
Average 90 stars, based on 1 article reviews
opaque flat caps - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Combining genomic analyses with tumour-derived slice cultures for the characterization of an EGFR -activating kinase mutation in a case of glioblastoma Article Snippet: Lastly, samples were sealed with Article Title: Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations Article Snippet: Finally, samples were sealed with Article Title: Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations. Article Snippet: Finally, samples were sealed with Fluorescence:Article Title: Circulating Tumor DNA Measurement by Picoliter Droplet-Based Digital PCR and Vemurafenib Plasma Concentrations in Patients with Advanced BRAF-Mutated Melanoma. Article Snippet: Background Circulating tumor DNA (ctDNA) has been reported as a prognostic marker in melanoma.. In BRAF V600mutant melanoma, a plasma under-exposure to vemurafenib could favor emerging resistance but no biological data are available to support this hypothesis.. Objective We aimed to investigate the relationship between vemurafenib plasma concentrations and the ctDNA plasma concentration during follow-up of BRAF-mutated melanoma patients. |